MedCity News April 4, 2024
Chicago-based Prenosis gained FDA clearance for its sepsis detection technology this week, marking the first time the agency has cleared an AI diagnostic tool for sepsis.
This week, Prenosis gained FDA clearance for its sepsis detection technology — marking the first time the agency has cleared an AI diagnostic tool for sepsis.
Chicago-based Prenosis was founded in 2014 with “a mission to bring precision medicine to acute care,” said CEO and Co-founder Bobby Reddy in an interview.
“We want each patient in the hospital to be treated based on their biology,” he explained. “We realized that, unfortunately, a lot of the technology in hospitals is focused around protocols — meaning that you would treat a patient that is 25 years...
Today's Sponsors
Today's Sponsor